Your browser doesn't support javascript.
loading
Correction to: A Computational Platform Integrating a Mechanistic Model of Crohn's Disease for Predicting Temporal Progression of Mucosal Damage and Healing.
Venkatapurapu, Sai Phanindra; Iwakiri, Ryuichi; Udagawa, Eri; Patidar, Nikhil; Qi, Zhen; Takayama, Ryoko; Kumar, Kei; Sato, Yuki; Behar, Marcelo; Offner, Patrick; Dwivedi, Gaurav; Miyasaka, Haruna; Suzuki, Ryohsuke Ken; Hamada, Anna Lissa; D'Alessandro, Paul M; Fernandez, Jovelle.
Afiliación
  • Venkatapurapu SP; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA. sai.phanindra.venkatapurapu@pwc.com.
  • Iwakiri R; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Udagawa E; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Patidar N; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Qi Z; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Takayama R; PwC Consulting LLC, Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Kumar K; PwC Consulting LLC, Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Sato Y; PwC Consulting LLC, Otemachi One Tower, 1-2-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
  • Behar M; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Offner P; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Dwivedi G; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Miyasaka H; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Suzuki RK; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Hamada AL; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • D'Alessandro PM; PricewaterhouseCoopers LLP, 301 Grant Street, Suite 4500, Pittsburgh, PA, 15219, USA.
  • Fernandez J; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Adv Ther ; 40(2): 721, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36512285
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos